 | • レポートコード：QYR9ST00780 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の喘息及びCOPD薬市場について調査・分析し、以下の構成でお届け致します。喘息及びCOPD薬の種類別には、COPD、喘息に、用途別には、コンビネーション製品、ロイコトリエン拮抗薬（LTA）、吸入コルチコステロイド（ICS）、抗コリン薬、短時間作用型ベータアゴニスト（SABA）、長時間作用型ベータアゴニスト（LABA）、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別喘息及びCOPD薬売上データ ・地域別喘息及びCOPD薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別喘息及びCOPD薬市場規模：COPD、喘息 ・用途別喘息及びCOPD薬市場規模：コンビネーション製品、ロイコトリエン拮抗薬（LTA）、吸入コルチコステロイド（ICS）、抗コリン薬、短時間作用型ベータアゴニスト（SABA）、長時間作用型ベータアゴニスト（LABA）、その他 ・主要メーカーの企業情報：GlaxoSmithKline、Novartis、Merck、Abbott Laboratories、Boehringer Ingelheim、AstraZeneca、Roche Holding AG、Teva Pharmaceutical Industries、Vectura Group、Pfizer ・喘息及びCOPD薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Asthma is a chronic respiratory disease blocking the airways of lung because of inflammation, mucus production, tighten of muscles. Chronic Obstructive Pulmonary Disease(COPD) is caused by obstruction in the airways causing difficulty in breathing, with the primary cause as tobacco smoking.The Global Asthma and COPD Drugs market is segmented based on disease, medication class and geography. Based on disease, the market is categorized into asthma and COPD.
The global Asthma and COPD Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Asthma and COPD Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Asthma and COPD Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Asthma and COPD Drugs in these regions.
This research report categorizes the global Asthma and COPD Drugs market by top players/brands, region, type and end user. This report also studies the global Asthma and COPD Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GlaxoSmithKline
Novartis
Merck
Abbott Laboratories
Boehringer Ingelheim
AstraZeneca
Roche Holding AG
Teva Pharmaceutical Industries
Vectura Group
Pfizer
Market size by Product
COPD
Asthma
Market size by End User
Combination Products
Leukotriene Antagonists (LTA)
Inhaled Corticosteroids (ICS)
Anticholinergics
Short Acting Beta Agonists(SABA)
Long Acting Beta Agonists (LABA)
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Asthma and COPD Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Asthma and COPD Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Asthma and COPD Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Asthma and COPD Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Asthma and COPD Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Asthma and COPD Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Asthma and COPD Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Asthma and COPD Drugs Market Size Growth Rate by Product
1.4.2 COPD
1.4.3 Asthma
1.5 Market by End User
1.5.1 Global Asthma and COPD Drugs Market Size Growth Rate by End User
1.5.2 Combination Products
1.5.3 Leukotriene Antagonists (LTA)
1.5.4 Inhaled Corticosteroids (ICS)
1.5.5 Anticholinergics
1.5.6 Short Acting Beta Agonists(SABA)
1.5.7 Long Acting Beta Agonists (LABA)
1.5.8 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Asthma and COPD Drugs Market Size
2.1.1 Global Asthma and COPD Drugs Revenue 2014-2025
2.1.2 Global Asthma and COPD Drugs Sales 2014-2025
2.2 Asthma and COPD Drugs Growth Rate by Regions
2.2.1 Global Asthma and COPD Drugs Sales by Regions
2.2.2 Global Asthma and COPD Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Asthma and COPD Drugs Sales by Manufacturers
3.1.1 Asthma and COPD Drugs Sales by Manufacturers
3.1.2 Asthma and COPD Drugs Sales Market Share by Manufacturers
3.1.3 Global Asthma and COPD Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Asthma and COPD Drugs Revenue by Manufacturers
3.2.1 Asthma and COPD Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Asthma and COPD Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Asthma and COPD Drugs Price by Manufacturers
3.4 Asthma and COPD Drugs Manufacturing Base Distribution, Product Types
3.4.1 Asthma and COPD Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Asthma and COPD Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Asthma and COPD Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Asthma and COPD Drugs Sales by Product
4.2 Global Asthma and COPD Drugs Revenue by Product
4.3 Asthma and COPD Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Asthma and COPD Drugs Breakdown Data by End User
6 North America
6.1 North America Asthma and COPD Drugs by Countries
6.1.1 North America Asthma and COPD Drugs Sales by Countries
6.1.2 North America Asthma and COPD Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Asthma and COPD Drugs by Product
6.3 North America Asthma and COPD Drugs by End User
7 Europe
7.1 Europe Asthma and COPD Drugs by Countries
7.1.1 Europe Asthma and COPD Drugs Sales by Countries
7.1.2 Europe Asthma and COPD Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Asthma and COPD Drugs by Product
7.3 Europe Asthma and COPD Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Asthma and COPD Drugs by Countries
8.1.1 Asia Pacific Asthma and COPD Drugs Sales by Countries
8.1.2 Asia Pacific Asthma and COPD Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Asthma and COPD Drugs by Product
8.3 Asia Pacific Asthma and COPD Drugs by End User
9 Central & South America
9.1 Central & South America Asthma and COPD Drugs by Countries
9.1.1 Central & South America Asthma and COPD Drugs Sales by Countries
9.1.2 Central & South America Asthma and COPD Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Asthma and COPD Drugs by Product
9.3 Central & South America Asthma and COPD Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Asthma and COPD Drugs by Countries
10.1.1 Middle East and Africa Asthma and COPD Drugs Sales by Countries
10.1.2 Middle East and Africa Asthma and COPD Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Asthma and COPD Drugs by Product
10.3 Middle East and Africa Asthma and COPD Drugs by End User
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 Company Business Overview
11.1.3 GlaxoSmithKline Asthma and COPD Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 GlaxoSmithKline Asthma and COPD Drugs Products Offered
11.1.5 GlaxoSmithKline Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Company Business Overview
11.2.3 Novartis Asthma and COPD Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Novartis Asthma and COPD Drugs Products Offered
11.2.5 Novartis Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Company Business Overview
11.3.3 Merck Asthma and COPD Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Merck Asthma and COPD Drugs Products Offered
11.3.5 Merck Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Company Business Overview
11.4.3 Abbott Laboratories Asthma and COPD Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Abbott Laboratories Asthma and COPD Drugs Products Offered
11.4.5 Abbott Laboratories Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Company Business Overview
11.5.3 Boehringer Ingelheim Asthma and COPD Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Boehringer Ingelheim Asthma and COPD Drugs Products Offered
11.5.5 Boehringer Ingelheim Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 Company Business Overview
11.6.3 AstraZeneca Asthma and COPD Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 AstraZeneca Asthma and COPD Drugs Products Offered
11.6.5 AstraZeneca Recent Development
11.7 Roche Holding AG
11.7.1 Roche Holding AG Company Details
11.7.2 Company Business Overview
11.7.3 Roche Holding AG Asthma and COPD Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Roche Holding AG Asthma and COPD Drugs Products Offered
11.7.5 Roche Holding AG Recent Development
11.8 Teva Pharmaceutical Industries
11.8.1 Teva Pharmaceutical Industries Company Details
11.8.2 Company Business Overview
11.8.3 Teva Pharmaceutical Industries Asthma and COPD Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Teva Pharmaceutical Industries Asthma and COPD Drugs Products Offered
11.8.5 Teva Pharmaceutical Industries Recent Development
11.9 Vectura Group
11.9.1 Vectura Group Company Details
11.9.2 Company Business Overview
11.9.3 Vectura Group Asthma and COPD Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Vectura Group Asthma and COPD Drugs Products Offered
11.9.5 Vectura Group Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Company Business Overview
11.10.3 Pfizer Asthma and COPD Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Pfizer Asthma and COPD Drugs Products Offered
11.10.5 Pfizer Recent Development
12 Future Forecast
12.1 Asthma and COPD Drugs Market Forecast by Regions
12.1.1 Global Asthma and COPD Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Asthma and COPD Drugs Revenue Forecast by Regions 2019-2025
12.2 Asthma and COPD Drugs Market Forecast by Product
12.2.1 Global Asthma and COPD Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Asthma and COPD Drugs Revenue Forecast by Product 2019-2025
12.3 Asthma and COPD Drugs Market Forecast by End User
12.4 North America Asthma and COPD Drugs Forecast
12.5 Europe Asthma and COPD Drugs Forecast
12.6 Asia Pacific Asthma and COPD Drugs Forecast
12.7 Central & South America Asthma and COPD Drugs Forecast
12.8 Middle East and Africa Asthma and COPD Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Asthma and COPD Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Asthma and COPD Drugs Product Picture
Table Asthma and COPD Drugs Market Segments
Table Key Manufacturers Asthma and COPD Drugs Covered
Table Global Asthma and COPD Drugs Market Size Growth Rate by Product 2019-2025 (K MT) & (Million US$)
Figure Global Asthma and COPD Drugs Sales Market Share by Product 2014-2025
Figure COPD Product Picture
Table Major Manufacturers of COPD
Figure Asthma Product Picture
Table Major Manufacturers of Asthma
Table Global Asthma and COPD Drugs Market Size Growth Rate by End User 2019-2025 (K MT)
Figure Combination Products
Figure Leukotriene Antagonists (LTA)
Figure Inhaled Corticosteroids (ICS)
Figure Anticholinergics
Figure Short Acting Beta Agonists(SABA)
Figure Long Acting Beta Agonists (LABA)
Figure Others
Figure Asthma and COPD Drugs Report Years Considered
Figure Global Asthma and COPD Drugs Market Size 2014-2025 (Million US$)
Figure Global Asthma and COPD Drugs Sales 2014-2025 (K MT)
Table Global Asthma and COPD Drugs Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Asthma and COPD Drugs Sales by Regions 2014-2019 (K MT)
Table Global Asthma and COPD Drugs Sales Market Share by Regions 2014-2019
Figure Global Asthma and COPD Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Asthma and COPD Drugs Sales Market Share by Regions
Table Global Asthma and COPD Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Asthma and COPD Drugs Revenue Market Share by Regions 2014-2019
Figure Global Asthma and COPD Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Asthma and COPD Drugs Revenue Market Share by Regions
Table Global Asthma and COPD Drugs Sales by Manufacturers (2014-2019) (K MT)
Table Global Asthma and COPD Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Asthma and COPD Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Asthma and COPD Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Asthma and COPD Drugs Revenue Share by Manufacturers (2014-2019)
Figure Asthma and COPD Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Asthma and COPD Drugs Price (2014-2019) (USD/MT)
Table Asthma and COPD Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Asthma and COPD Drugs Product Type
Table Date of International Manufacturers Enter into Asthma and COPD Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Asthma and COPD Drugs Sales by Product (2014-2019) (K MT)
Table Global Asthma and COPD Drugs Sales Share by Product (2014-2019)
Figure Global Asthma and COPD Drugs Sales Market Share by Product (2014-2019)
Figure Global Asthma and COPD Drugs Sales Market Share by Product in 2018
Table Global Asthma and COPD Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Asthma and COPD Drugs Revenue Share by Product (2014-2019)
Figure Global Asthma and COPD Drugs Revenue Market Share by Product (2014-2019)
Figure Global Asthma and COPD Drugs Revenue Market Share by Product in 2018
Table Asthma and COPD Drugs Price by Product 2014-2019 (USD/MT)
Table Global Asthma and COPD Drugs Sales by End User (2014-2019) (K MT)
Table Global Asthma and COPD Drugs Sales Share by End User (2014-2019)
Figure Global Sales Asthma and COPD Drugs Market Share by End User (2014-2019)
Figure Global Sales Asthma and COPD Drugs Market Share by End User in 2018
Figure North America Asthma and COPD Drugs Sales Growth Rate 2014-2019 (K MT)
Figure North America Asthma and COPD Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Asthma and COPD Drugs Sales by Countries (2014-2019) (K MT)
Table North America Asthma and COPD Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Asthma and COPD Drugs Sales Market Share by Countries
Table North America Asthma and COPD Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Asthma and COPD Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Asthma and COPD Drugs Revenue Market Share by Countries
Figure United States Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure United States Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (K MT)
Figure Canada Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Canada Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Mexico Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Asthma and COPD Drugs Sales by Product (2014-2019) (K MT)
Table North America Asthma and COPD Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Asthma and COPD Drugs Market Share by Product
Table North America Asthma and COPD Drugs Sales by End User (2014-2019) (K MT)
Table North America Asthma and COPD Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Asthma and COPD Drugs Market Share by End User
Figure Europe Asthma and COPD Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Europe Asthma and COPD Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Asthma and COPD Drugs Sales by Countries (2014-2019) (K MT)
Table Europe Asthma and COPD Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Asthma and COPD Drugs Sales Market Share by Countries
Table Europe Asthma and COPD Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Asthma and COPD Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Asthma and COPD Drugs Revenue Market Share by Countries
Figure Germany Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Germany Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure France Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure UK Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Italy Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Russia Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Asthma and COPD Drugs Sales by Product (2014-2019) (K MT)
Table Europe Asthma and COPD Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Asthma and COPD Drugs Market Share by Product
Table Europe Asthma and COPD Drugs Sales by End User (2014-2019) (K MT)
Table Europe Asthma and COPD Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Asthma and COPD Drugs Market Share by End User
Figure Asia Pacific Asthma and COPD Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Asia Pacific Asthma and COPD Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Asthma and COPD Drugs Sales by Countries (2014-2019) (K MT)
Table Asia Pacific Asthma and COPD Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Asthma and COPD Drugs Sales Market Share by Countries
Table Asia Pacific Asthma and COPD Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Asthma and COPD Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Asthma and COPD Drugs Revenue Market Share by Countries
Figure China Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure China Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Japan Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Korea Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure India Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Australia Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Indonesia Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Malaysia Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Philippines Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Thailand Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Vietnam Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Singapore Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Asthma and COPD Drugs Sales by Product (2014-2019) (K MT)
Table Asia Pacific Asthma and COPD Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Asthma and COPD Drugs Market Share by Product
Table Asia Pacific Asthma and COPD Drugs Sales by End User (2014-2019) (K MT)
Table Asia Pacific Asthma and COPD Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Asthma and COPD Drugs Market Share by End User
Figure Central & South America Asthma and COPD Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Central & South America Asthma and COPD Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Asthma and COPD Drugs Sales by Countries (2014-2019) (K MT)
Table Central & South America Asthma and COPD Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Asthma and COPD Drugs Sales Market Share by Countries
Table Central & South America Asthma and COPD Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Asthma and COPD Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Asthma and COPD Drugs Revenue Market Share by Countries
Figure Brazil Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Brazil Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Argentina Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Asthma and COPD Drugs Sales by Product (2014-2019) (K MT)
Table Central & South America Asthma and COPD Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Asthma and COPD Drugs Market Share by Product
Table Central & South America Asthma and COPD Drugs Sales by End User (2014-2019) (K MT)
Table Central & South America Asthma and COPD Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Asthma and COPD Drugs Market Share by End User
Figure Middle East and Africa Asthma and COPD Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Middle East and Africa Asthma and COPD Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Asthma and COPD Drugs Sales by Countries (2014-2019) (K MT)
Table Middle East and Africa Asthma and COPD Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Asthma and COPD Drugs Sales Market Share by Countries
Table Middle East and Africa Asthma and COPD Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Asthma and COPD Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Asthma and COPD Drugs Revenue Market Share by Countries
Figure GCC Countries Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure GCC Countries Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Turkey Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Egypt Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Asthma and COPD Drugs Sales Growth Rate (2014-2019) (K MT)
Figure South Africa Asthma and COPD Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Asthma and COPD Drugs Sales by Product (2014-2019) (K MT)
Table Middle East and Africa Asthma and COPD Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Asthma and COPD Drugs Market Share by Product
Table Middle East and Africa Asthma and COPD Drugs Sales by End User (2014-2019) (K MT)
Table Middle East and Africa Asthma and COPD Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Asthma and COPD Drugs Market Share by End User
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Asthma and COPD Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Novartis Company Details
Table Novartis Asthma and COPD Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Merck Company Details
Table Merck Asthma and COPD Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Asthma and COPD Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Abbott Laboratories Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Asthma and COPD Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Asthma and COPD Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Roche Holding AG Company Details
Table Roche Holding AG Asthma and COPD Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Roche Holding AG Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Asthma and COPD Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Recent Development
Table Vectura Group Company Details
Table Vectura Group Asthma and COPD Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Vectura Group Recent Development
Table Pfizer Company Details
Table Pfizer Asthma and COPD Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Global Asthma and COPD Drugs Sales Forecast by Regions 2019-2025 (K MT)
Table Global Asthma and COPD Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Asthma and COPD Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Asthma and COPD Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Asthma and COPD Drugs Sales Forecast by Product 2019-2025 (K MT)
Table Global Asthma and COPD Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Asthma and COPD Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Asthma and COPD Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Asthma and COPD Drugs Sales Forecast by End User 2019-2025 (K MT)
Table Global Asthma and COPD Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Asthma and COPD Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure North America Asthma and COPD Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Asthma and COPD Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Europe Asthma and COPD Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Asthma and COPD Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Asia Pacific Asthma and COPD Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Asthma and COPD Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Central & South America Asthma and COPD Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Asthma and COPD Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Middle East and Africa Asthma and COPD Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Asthma and COPD Drugs Value Chain
Table Asthma and COPD Drugs Customers List
Table Asthma and COPD Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
喘息及びCOPD薬の世界市場：インサイト・予測 Asthma and chronic obstructive pulmonary disease (Asthma/COPD) are a common type of chronic disease. Once they are sick, they usually need long-term medication, which seriously affects people's quality of life.The 2016 Global Asthma Prevention Initiative (GINA) organization has re-released its Conse…- 世界のCOPD・喘息治療薬市場：動向・競争分析 The COPD and Asthma Drug Devices market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for…
- COPD薬の世界市場：市場規模・現状・予測 COPD drugs is a medicine used to treatment chronic obstructive pulmonary disease, such as bronchodilators, pde-4 inhibitors， steroids, combination therapies, etc.One of the emerging trends propelling the growth prospects for this market is the augmented focus and use of combination therapies to trea…
- 肺薬の世界市場：インサイト・予測 The pulmonary drugs are used for treating the conditions affecting lungs. The pulmonary drugs are used from treating minor illnesses such as the common cold to cure long-term disorders such asthma. These agents are available in different forms such as oral tablets, oral liquids, and injections or in…
- 予防喘息薬の世界市場：インサイト・予測 Drugs for asthma attacks are bronchodilators. The products include pills, potions, inhalers and sprays. The effect is bronchiectasis, which can relieve asthma symptoms quickly and help prevent asthma attacks. This kind of medicine works well and is quite safe. But be careful not to overuse it. The m…